Little is known about lipid changes that occur in the setting of metabolic-dysfunction-
associated steatotic liver disease (MASLD) regression. We previously reported …

Dietary sugar reduction is one therapeutic strategy for improving nonalcoholic fatty liver
disease (NAFLD), and the underlying mechanisms for this effect warrant further …

Background: Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly
known as NAFLD, is the most common liver disease in children. Liver biopsy remains the …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing healthcare
problem with limited therapeutic options. Progress in this field depends on the availability of …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as
nonalcoholic fatty liver disease (NAFLD), is the main cause of chronic liver disease in …

Metabolic dysfunction-associated steatotic liver disease (MASLD), once known as non-
alcoholic fatty liver disease (NAFLD), represents a spectrum of liver disorders characterized …

The term “non-alcoholic fatty liver disease”(NAFLD) has been, for a long time, used to
describe the spectrum of liver lesions encompassing steatosis, steatohepatitis (NASH), and …

Backround Metabolic dysfunction-associated steatotic liver disease (MASLD) can lead to
liver fibrosis, cirrhosis, and hepatocellular carcinoma. Still, most patients with MASLD die …

Obesity and metabolic syndrome are linked to steatotic liver disease (SLD), the most
common form of chronic liver disease. Lifestyle modifications and dieting are strategies that …

Multiple changes in lipid metabolism occur in nonalcoholic fatty liver disease. However, it is
not known which of these contribute to disease progression. The objective of this study was …